SLC6A3 and Parkinson disease: Integrity of DAT function is central in the regulation of dopamine levels in the synaptic cleft, and a gradual loss of DAT availability as PD progresses results in the loss of compensatory reuptake needed when dopamine levels substantially rise after a dose of levodopa [48].